|
Volumn 42, Issue 4, 2001, Pages 596-600
|
Methylxanthine sensitization of human colon cancer cells to 186Re-labeled monoclonal antibody
a a a a a a a a a a |
Author keywords
irradiation; 186Re; Cell cycle; Methylxanthine; Radiosensitization
|
Indexed keywords
CAFFEINE;
MERTIATIDE RE 186;
METHYLXANTHINE;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY A7;
MONOCLONAL ANTIBODY A7 MERTIATIDE RE 186;
PENTOXIFYLLINE;
RADIOSENSITIZING AGENT;
RHENIUM 186;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER CELL;
CELL CYCLE;
CELL KILLING;
COLON CANCER;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG EFFECT;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
RADIOSENSITIZATION;
TUMOR SUPPRESSOR GENE;
ANTIBODIES, MONOCLONAL;
CELL CYCLE;
CELL SURVIVAL;
COLONIC NEOPLASMS;
GENES, P53;
HUMANS;
INTERPHASE;
OLIGOPEPTIDES;
ORGANOMETALLIC COMPOUNDS;
RADIATION TOLERANCE;
RADIATION-SENSITIZING AGENTS;
RADIOPHARMACEUTICALS;
RHENIUM;
TUMOR CELLS, CULTURED;
TUMOR STEM CELL ASSAY;
XANTHINES;
|
EID: 0035043894
PISSN: 01615505
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (37)
|